ADAR1 Capital Management »

Helix Acquisition Corp Ii Cl A shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Helix Acquisition Corp Ii Cl A (HLXB) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Helix Acquisition Corp Ii Cl A

Tip: Access up to 7 years of quarterly data

All positions including Helix Acquisition Corp Ii Cl A held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Helix Acquisition Corp Ii Cl A by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $4.2M 404k 10.40

More positions owned by ADAR1 Capital Management

Alnylam Pharmaceuticals (ALNY)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Roivant Sciences SHS (ROIV)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Protagonist Therapeutics (PTGX)
Cytokinetics Com New (CYTK)
Keros Therapeutics (KROS)
Royalty Pharma Shs Class A (RPRX)
Bridgebio Pharma (BBIO)
Merrimack Pharmaceuticals In Com New
Ascendis Pharma A/s Sponsored Adr (ASND)
Arbutus Biopharma (ABUS)
Avrobio Ord (AVRO)
Beigene Sponsored Adr (BGNE)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)

View all positions for ADAR1 Capital Management

Top funds holding Helix Acquisition Corp Ii Cl A

Cormorant Asset Management
BlackRock
Adage Capital Partners GP
Citadel Advisors
T. Rowe Price Associates
Millennium Management
OZ Management
Farallon Capital Management
Dr. Jeffrey R. Jay, M.D.
Silverarc Capital Management
Perceptive Advisors
Commodore Capital
Soros Fund Management
ADAR1 Capital Management
T. Rowe Price Investment Management

View all funds holding Helix Acquisition Corp Ii Cl A